Community-Acquired Pneumonia in Adults: Rapid Evidence Review

Area of Science:

• Infectious Diseases
• Pulmonology
• Primary Care Medicine

Background:

• Community-acquired pneumonia (CAP) is a significant cause of morbidity and mortality, particularly in older adults.
• Pathogen identification in CAP is often challenging, with a substantial proportion of cases remaining without a confirmed organism.
• Early diagnosis and appropriate risk stratification are crucial for effective management of CAP.

Purpose of the Study:

• To provide an overview of current diagnostic and treatment strategies for community-acquired pneumonia.
• To highlight the role of clinical signs, symptoms, and imaging in CAP diagnosis.
• To outline recommended vaccination strategies for preventing pneumococcal infections.

Main Methods:

• Review of diagnostic approaches including history, physical examination, and imaging modalities like chest radiography, lung ultrasonography, and CT scans.
• Discussion of the CRB-65 score for risk stratification in primary care.
• Summary of antibiotic treatment recommendations based on patient comorbidities, disease severity, and local resistance patterns.
• Overview of pneumococcal and other relevant vaccinations for at-risk populations.

Main Results:

• Diagnosis of CAP relies on a combination of clinical assessment and imaging; procalcitonin measurement is not recommended.
• The CRB-65 score is a validated tool for risk stratification in primary care settings.
• Treatment strategies vary, including amoxicillin, doxycycline, macrolides, beta-lactams, cephalosporins, or fluoroquinolones, depending on patient factors and pathogen resistance.
• Specific recommendations exist for treating methicillin-resistant Staphylococcus aureus or Pseudomonas infections.
• Updated guidelines recommend the 20-valent pneumococcal conjugate vaccine or a sequential regimen of 15-valent conjugate followed by 23-valent polysaccharide vaccine for older adults and those with underlying conditions.

Conclusions:

• Effective management of CAP requires accurate diagnosis, appropriate risk stratification using tools like CRB-65, and tailored antimicrobial therapy.
• Vaccination with updated pneumococcal vaccines is essential for preventing CAP in high-risk individuals.
• Annual influenza and SARS-CoV-2 vaccinations are recommended for all adults to prevent respiratory infections.